(Q43544652)

24 November 2017

title

A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A southwest oncology group study (English)

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

9 December 2022

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

9 December 2022

author name string

C. S. Higano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849785

9 December 2022

J. Crowley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849785

9 December 2022

R. B. Livingston

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849785

9 December 2022

J. W. Goodwin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849785

9 December 2022

B. Barlogie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849785

9 December 2022

W. J. Stuckey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849785

9 December 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

24 November 2017

15 May 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1849785

full work available at URL

9 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

9 December 2022

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

9 December 2022

1 reference

24 November 2017

volume

67

1 reference

24 November 2017

issue

10

1 reference

24 November 2017

page(s)

2439-2442

1 reference

Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study

24 November 2017

cites work

1

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

9 December 2022

3

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

9 December 2022

4

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

9 December 2022

6

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinoma

9 December 2022

7

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

Nonparametric Estimation from Incomplete Observations

9 December 2022

9

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

High-Dose Cisplatin in Hypertonic Saline

9 December 2022

11

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity

9 December 2022

12

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

9 December 2022

Cancer Treatment Reports

13

70

820

Gandara

1986

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

High-dose cisplatin in patients with advanced malignancies.

9 December 2022

14

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

9 December 2022

15

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen

9 December 2022

16

1 reference

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2439::AID-CNCR2820671007%3E3.0.CO;2-6

9 December 2022

Identifiers

10.1002/1097-0142(19910515)67:10<2439::AID-CNCR2820671007>3.0.CO;2-6

1 reference

24 November 2017

1 reference